<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effects of the <z:chebi fb="1" ids="38215">calcium channel blocker</z:chebi> nimodipine and the non-competitive <z:chebi fb="0" ids="31882">NMDA</z:chebi>-<z:chebi fb="68" ids="48706">antagonists</z:chebi> MK-801 and phencyclidine (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e>) on <z:mpath ids='MPATH_124'>infarct</z:mpath> size 48 h after occlusion of the middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>-O) were evaluated in the rat </plain></SENT>
<SENT sid="1" pm="."><plain>Nimodipine was given at a dose of 0.3 mg/kg s.c </plain></SENT>
<SENT sid="2" pm="."><plain>30 min prior and 8, 16, and 24 h after <z:chebi fb="70" ids="34342">MCA</z:chebi>-O </plain></SENT>
<SENT sid="3" pm="."><plain>MK-801 (1 mg/kg i.p. or 10 mg/kg i.p.) or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> (0.3, 1.0, 3.0, 10, or 30 mg/kg i.p.) were administered 30 min prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In additional experiments 30 mg/kg <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> was given 1, 3, or 5 h post <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Nimodipine and 1 mg/kg MK-801 reduced cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes significantly by 50% and 55%, respectively, while cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> size fell by 32% and total <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was not altered significantly after administration of 10 mg/kg MK-801 </plain></SENT>
<SENT sid="6" pm="."><plain>Pretreatment with 10 or 30 mg/kg <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> reduced cortical infarction by 47-53% and total <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes by 39-42% </plain></SENT>
<SENT sid="7" pm="."><plain>Posttreatment with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> was effective if started at 1 or 3 h post <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>